Biopharma Manufacturers Shouldn't Rush When "Going Digital"
Biopharma Manufacturers Shouldnât Rush When âGoing Digitalâ Digitizing manufacturing activities requires strong management and a stepwise approach to implementations [SolStock/Getty Images] Share Digitization is a hot topic in biopharma. In recent years, AstraZeneca, Novartis, and Sanofi have each unveiled plans to use data to link drug development, manufacturing, and distribution, citing speed and efficiency as motivation for the investments. These investments show biopharma is finally recognizing the benefits of digital manufacturing, according to Trent Munro, PhD, professor...
Source: genengnews.com